Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice.

Hu Z, Wong KW, Zhao HM, Wen HL, Ji P, Ma H, Wu K, Lu SH, Li F, Li ZM, Shu T, Xu JQ, Lowrie DB, Fan XY.

Mol Ther. 2017 May 3;25(5):1222-1233. doi: 10.1016/j.ymthe.2017.02.018. Epub 2017 Mar 23.

2.

Protection Induced by Simultaneous Subcutaneous and Endobronchial Vaccination with BCG/BCG and BCG/Adenovirus Expressing Antigen 85A against Mycobacterium bovis in Cattle.

Dean GS, Clifford D, Whelan AO, Tchilian EZ, Beverley PC, Salguero FJ, Xing Z, Vordermeier HM, Villarreal-Ramos B.

PLoS One. 2015 Nov 6;10(11):e0142270. doi: 10.1371/journal.pone.0142270. eCollection 2015.

3.

Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety Considerations.

Leunda A, Baldo A, Goossens M, Huygen K, Herman P, Romano M.

Vaccines (Basel). 2014 Jun 16;2(2):463-99. doi: 10.3390/vaccines2020463. Review.

4.

Tuberculosis vaccine development: Shifting focus amid increasing development challenges.

Graves AJ, Hokey DA.

Hum Vaccin Immunother. 2015;11(8):1910-6. doi: 10.1080/21645515.2015.1040955.

5.

Characterization of effector and memory T cell subsets in the immune response to bovine tuberculosis in cattle.

Maggioli MF, Palmer MV, Thacker TC, Vordermeier HM, Waters WR.

PLoS One. 2015 Apr 16;10(4):e0122571. doi: 10.1371/journal.pone.0122571. eCollection 2015.

6.

The evolution of poxvirus vaccines.

Sánchez-Sampedro L, Perdiguero B, Mejías-Pérez E, García-Arriaza J, Di Pilato M, Esteban M.

Viruses. 2015 Apr 7;7(4):1726-803. doi: 10.3390/v7041726. Review.

7.

Aerosol immunisation for TB: matching route of vaccination to route of infection.

Manjaly Thomas ZR, McShane H.

Trans R Soc Trop Med Hyg. 2015 Mar;109(3):175-81. doi: 10.1093/trstmh/tru206. Epub 2015 Jan 30. Review.

8.

Efficacy of a vaccine formula against tuberculosis in cattle.

Canto Alarcon GJ, Rubio Venegas Y, Bojorquez Narvaez L, Pizano Martínez OE, García Casanova L, Sosa Gallegos S, Nava Vargas A, Olvera Ramírez AM, Milian Suazo F.

PLoS One. 2013 Oct 18;8(10):e76418. doi: 10.1371/journal.pone.0076418. eCollection 2013.

9.

Potential application of new diagnostic methods for controlling bovine tuberculosis in Brazil.

Medeiros Ldos S, Marassi CD, Figueiredo EE, Lilenbaum W.

Braz J Microbiol. 2010 Jul;41(3):531-41. doi: 10.1590/S1517-83822010005000002. Epub 2010 Sep 1.

10.

Prime-boost approaches to tuberculosis vaccine development.

Dalmia N, Ramsay AJ.

Expert Rev Vaccines. 2012 Oct;11(10):1221-33. doi: 10.1586/erv.12.94. Review.

11.

Opportunities for improved serodiagnosis of human tuberculosis, bovine tuberculosis, and paratuberculosis.

Wadhwa A, Hickling GJ, Eda S.

Vet Med Int. 2012;2012:674238. doi: 10.1155/2012/674238. Epub 2012 Jun 6.

12.

Modified vaccinia virus Ankara-based vaccine vectors induce apoptosis in dendritic cells draining from the skin via both the extrinsic and intrinsic caspase pathways, preventing efficient antigen presentation.

Guzman E, Cubillos-Zapata C, Cottingham MG, Gilbert SC, Prentice H, Charleston B, Hope JC.

J Virol. 2012 May;86(10):5452-66. doi: 10.1128/JVI.00264-12. Epub 2012 Mar 14.

13.

Improved skin test for differential diagnosis of bovine tuberculosis by the addition of Rv3020c-derived peptides.

Jones GJ, Whelan A, Clifford D, Coad M, Vordermeier HM.

Clin Vaccine Immunol. 2012 Apr;19(4):620-2. doi: 10.1128/CVI.00024-12. Epub 2012 Feb 1.

14.

Robust immune response elicited by a novel and unique Mycobacterium tuberculosis protein using an optimized DNA/protein heterologous prime/boost protocol.

Cayabyab MJ, Kashino SS, Campos-Neto A.

Immunology. 2012 Mar;135(3):216-25. doi: 10.1111/j.1365-2567.2011.03525.x.

15.

Immunogenicity and protective efficacy against murine tuberculosis of a prime-boost regimen with BCG and a DNA vaccine expressing ESAT-6 and Ag85A fusion protein.

Lu J, Wang C, Zhou Z, Zhang Y, Cao T, Shi C, Chen Z, Chen L, Cai C, Fan X.

Clin Dev Immunol. 2011;2011:617892. doi: 10.1155/2011/617892. Epub 2011 Feb 27.

16.

Identification of surrogates and correlates of protection in protective immunity against Mycobacterium bovis infection induced in neonatal calves by vaccination with M. bovis BCG Pasteur and M. bovis BCG Danish.

Hope JC, Thom ML, McAulay M, Mead E, Vordermeier HM, Clifford D, Hewinson RG, Villarreal-Ramos B.

Clin Vaccine Immunol. 2011 Mar;18(3):373-9. doi: 10.1128/CVI.00543-10. Epub 2011 Jan 12.

17.

Screening of predicted secreted antigens from Mycobacterium bovis identifies potential novel differential diagnostic reagents.

Jones GJ, Hewinson RG, Vordermeier HM.

Clin Vaccine Immunol. 2010 Sep;17(9):1344-8. doi: 10.1128/CVI.00261-10. Epub 2010 Jul 28.

18.

Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing.

Sharpe SA, McShane H, Dennis MJ, Basaraba RJ, Gleeson F, Hall G, McIntyre A, Gooch K, Clark S, Beveridge NE, Nuth E, White A, Marriott A, Dowall S, Hill AV, Williams A, Marsh PD.

Clin Vaccine Immunol. 2010 Aug;17(8):1170-82. doi: 10.1128/CVI.00079-10. Epub 2010 Jun 9.

19.

Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant.

Kolibab K, Yang A, Derrick SC, Waldmann TA, Perera LP, Morris SL.

Clin Vaccine Immunol. 2010 May;17(5):793-801. doi: 10.1128/CVI.00006-10. Epub 2010 Mar 31.

20.

Recombinant Mycobacterium bovis BCG as an HIV vaccine vector.

Chapman R, Chege G, Shephard E, Stutz H, Williamson AL.

Curr HIV Res. 2010 Jun;8(4):282-98. Review.

Supplemental Content

Support Center